Sotagliflozin significantly lowers Heart Attack and Stroke Risk, reports Lancet study Dr. Kamal Kant Kohli20 Feb 2025 9:00 AM ISTSotagliflozin, recently approved by the FDA for treating type 2 diabetes and kidney disease in patients with cardiovascular risk factors, has been...
USFDA Approves Roche's Evrysdi Tablet for Spinal Muscular Atrophy Farhat Nasim15 Feb 2025 10:45 AM ISTEvrysdi is the only non-invasive disease-modifying treatment for SMA.
Single dose SelfJect corticotropin injection approved by FDA Dr. Kamal Kant Kohli11 Aug 2024 8:45 PM ISTThe US Food and Drug Administration (FDA) has granted approval for supplemental New Drug Application (sNDA) for 'Acthar Gel Single-Dose Pre-filled...
FDA Approves First Nasal Spray for emergency Treatment of serious allergies including Anaphylaxis Dr. Kamal Kant Kohli11 Aug 2024 8:15 PM ISTThe U S Food and Drug Administration has approved neffy (epinephrine nasal spray) for the emergency treatment of allergic reactions (Type I),...
FDA approves another drug for treatment of adults with early symptomatic Alzheimer's disease Dr. Kamal Kant Kohli3 July 2024 8:30 PM ISTThe US Food and Drug Administration has approved aother drug donanemab (Kisunla) for treatment of adults with early symptomatic Alzheimer's disease...
FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test Dr. Kamal Kant Kohli30 Jun 2024 8:00 PM ISTToday, the US Food and Drug Administration granted marketing authorization to Cepheid for the Xpert HCV test and GeneXpert Xpress System, the first...
FDA approves Benralizumab as Add-On Maintenance Therapy for kids aged 6 to 11 with severe asthma Dr. Kamal Kant Kohli15 April 2024 6:45 AM ISTAstraZeneca's FASENRA® (benralizumab) is now approved by the US Food and Drug Administration (FDA) for add-on maintenance treatment for patients with...
FDA clears non invasive device for treatment of anxiety Dr. Kamal Kant Kohli11 April 2024 10:00 PM ISTThe US Food and Drug Administration has cleared Modius Stress to treat generalized anxiety disorder.Made by Neurovalens is a non-invasive electrical...
FDA okays pemivibart to prevent COVID-19 in immunocompromised patients Dr. Kamal Kant Kohli26 March 2024 8:30 AM ISTFood and Drug Administration (FDA) has granted emergency use authorization (EUA) for monoclonal antibody pemivibart to prevent COVID-19 in...
Medical Bulletin 21/February/2024 Anshika Mishra21 Feb 2024 3:00 PM ISTHere are the top medical news highlights for the day:Remission of Cushing's disease increases the risk of autoimmune diseaseA cohort study of more...
FDA approves first-ever medication for severe frostbite treatment Anshika Mishra21 Feb 2024 9:30 AM ISTThe U.S. Food and Drug Administration (FDA) has approved Aurlumyn (iloprost) injection for treating severe frostbite in adults, aiming to decrease the...
Iloprost approved for treatment of Frostbite by USFDA Roshni Dhar19 Feb 2024 5:49 PM ISTThe Food and Drug Administration (FDA) has approved Aurlumyn (iloprost) for treatment of severe frostbite in adults which may eventually help reduce...
